Physician
Yerneni, Purnachandra
Yerneni, Purnachandra was paid $774K by Medicaid between Jan 2018 and Aug 2024, across 50 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 41% of everything it billed.
33Billing provider infoYERNENI, PURNACHANDRA
BOGALUSA, LA 70427
BOGALUSA, LA 70427
33aNPI1861571622assigned 11/03/2006
33bProvider typeInternal Medicine Physician
28Total paid$774K
24GClaims69,690
24DCodes billed50
24AFirst – last monthJan 2018 – Aug 2024
Compared with peers
Next to other Internal Medicine Physician providers in Louisiana
Rank by total paid#27 of 290
Median peer was paid$27K
This provider vs. median29×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31,524 | $405K | |
| 2019 | 14,115 | $106K | |
| 2020 | 9,597 | $61K | |
| 2021 | 3,946 | $40K | |
| 2022 | 2,779 | $50K | |
| 2023 | 6,738 | $96K | |
| 2024incomplete | 991 | $15K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 41% | 14,313 | 7,660 | $320K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 12% | 2,013 | 1,657 | $89K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 8.9% | 6,148 | 3,414 | $69K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 6.3% | 241 | 223 | $49K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 5.7% | 8,214 | 4,372 | $44K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4.9% | 976 | 475 | $38K |
| 82947 | 2.8% | 11,016 | 5,770 | $22K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.8% | 1,546 | 891 | $22K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.0% | 1,129 | 662 | $15K |
| 93880 | 1.7% | 161 | 123 | $13K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.7% | 1,709 | 1,465 | $13K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.6% | 125 | 112 | $13K |
38 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 1.4% | 163 | $11K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.3% | 347 | $10K |
| 93975 | <1% | 51 | $7K | |
| 95961 | <1% | 63 | $6K | |
| 93925 | <1% | 40 | $6K | |
| 95816 | <1% | 63 | $5K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 4,776 | $3K |
| 90674 | <1% | 239 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 270 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 250 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 71 | $2K |
| 90756 | <1% | 132 | $2K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 136 | $1K |
| 99442 | <1% | 251 | $1K | |
| 95957 | <1% | 65 | $771.99 | |
| 99307 | <1% | 157 | $575.19 | |
| 80305 | <1% | 85 | $493.68 | |
| 77085 | <1% | 15 | $386.60 | |
| 90688 | <1% | 35 | $356.80 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,981 | $341.68 |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 45 | $332.60 |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 26 | $275.10 |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 14 | $256.05 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 158 | $215.67 |
| 93050 | <1% | 70 | $173.04 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,723 | $113.19 |
| 86580 | <1% | 74 | $87.45 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 4,824 | $61.17 |
| 96138 | <1% | 16 | $54.94 | |
| J1815 | Injection, insulin, per 5 units | <1% | 108 | $17.24 |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 123 | $0.65 |
| G0008 | Administration of influenza virus vaccine | 0% | 97 | $0.00 |
| 3008F | 0% | 213 | $0.00 | |
| 99308 | Subsequent nursing facility care, per day, straightforward | 0% | 272 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 79 | $0.00 |
| 4040F | 0% | 12 | $0.00 | |
| J1000 | Injection, depo-estradiol cypionate, up to 5 mg | 0% | 42 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.